Use of thiazolide compounds for the prevention and treatment of viral diseases, cancer and diseases caused by intracellular infections
AssigneeRomark Laboratories L.C.
InventorJean-Francois Rossignol
Life of this patent
Estimating the term…
Abstract
The invention provides for the use of pharmaceutical compositions comprising a thiazolide in the stimulation of the immune system in a subject in need thereof, thereby preventing and/or treating viral diseases, cancer and diseases caused by intracellular protozoan infections.
Claims14
A method of inhibiting a replication of HIV comprising administering to a subject in need thereof a therapeutically effective amount of a thiazolide compound, wherein the thiazolide compound is nitazoxanide, tizoxanide, a mixture nitazoxanide and tizoxanide, N-(5-chlorothiazol-2-yl)-2-hydroxybenzamide, or a salt, ester, or amide thereof.
Dependencies are inferred from the claim text.